Study of Progression to Progressive Fibrosing Interstitial Lung Disease (PF-ILD) Incidence/Management and Treatment

NCT05875532 · clinicaltrials.gov ↗

COMPLETED

Status

34960

Enrollment

INDUSTRY

Sponsor class

Conditions

Lung Diseases, Interstitial

Sponsor

Boehringer Ingelheim